2021 Biopharma Outlook: Turning Uncertainty Into Opportunity
Source : IN VIVO
A singular focus on defeating COVID-19 will likely dominate the biopharma agenda at the beginning of 2021 and will determine how quickly the industry, and world, can bounce back to...
COVID Megalab To Boost Testing Infrastructure As UK Prepares For Future Diagnostic Needs
Source : Medtech Insight
A new “megalab” that will be able to process and sequence “hundreds of thousands” of COVID-19 samples a day has been opened in Royal Leamington Spa, UK. Its genotype assay...
DiaSorin Completes $1.8bn acquisition of Luminex
Source : Medtech Insight
Italian Diagnostics company DiaSorin SpA has completed its planned $1.8bn acquisition of Luminex Corporation, the company announced 14 July.
Under the terms of the deal announced in April, DiaSorin will...
FDA Issues New EUA Product Codes To Track Adverse Events, Imports
Source : Medtech Insight
The US Food and Drug Administration has published new product codes for emergency use authorized (EUA) products that have been allowed on the market during the COVID-19 pandemic.
The agency says...
MHRA Must Seize UK Digital And Diagnostics Opportunity: ABHI Perspectives On Enabling Regulation – Part 2
Source : Medtech Insight
The starting gun is yet to be fired for the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) consultation on the UKCA marking, which had initially been expected in early...